Novoviah Revenue

Biotechnology Research • Brisbane, Queensland, Australia • 11-20 Employees

Novoviah revenue & valuation

Annual revenue	$1,112,215
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,600,000
Total funding	No funding

Key Contact at Novoviah

Geoff Daly

Director Of Operations

Company overview

Headquarters	200 Adelaide St, Level 6, Brisbane City, Queensland 4000, AU
Website	novoviah.com
NAICS	541714
Keywords	Biotechnology, Type 1 Diabetes, Biomarkers, Diagnostics, Immunotherapy, Autoimmune, Celiac Disease, Melanoma, Solid Tumors
Founded	2020
Employees	11-20

Novoviah Email Formats

Novoviah uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@novoviah.com), used 60% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@novoviah.com	60%
{first initial}{last name}	jdoe@novoviah.com	40%

About Novoviah

At Novoviah, we make monitoring for rare antigen-specific T cells easy and sensitive for a clinical trial. Arising from our Founder’s 20+ years’ experience researching and studying celiac disease and inflammatory bowel diseases, Novoviah’s break-through foundation product is the proprietary Novoleukin Test System, a “whole blood antigen-stimulated cytokine release assay” which is substantially more sensitive than conventional fresh PBMC-based ELISpot assay and flow cytometry assays. Novoviah has demonstrated the success of the Novoleukin Test System as a ‘research only product’, firstly in Celiac Disease (Novoleukin-C, clinical validation stage); and is expanding to Type 1 Diabetes, and other medical conditions associated with antigen-specific T cells. Novoviah’s aspiration is to have a Novoleukin Test System available for a wide range of antigens relevant to immune disease, immunotherapies and vaccines, and to explore their clinical utility as diagnostics or monitoring tools. If you are a pharmaceutical or research company developing therapeutics or monitoring tools for indications where specific disease-associated antigen and T cell responses are implicated, contact us to discuss development of a highly sensitive Novoleukin Test System specific to your indication.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Director

Partner

Employees by Department

Novoviah has 3 employees across 1 departments.

Departments

Number of employees

Funding Data

Novoviah has never raised funding before.

Novoviah Tech Stack

Discover the technologies and tools that power Novoviah's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

reCAPTCHA

Security

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Snowplow Analytics

Analytics

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

Matomo Analytics

Analytics

Skrollr

JavaScript libraries

Google Analytics

Analytics

RSS

Miscellaneous

Frequently asked questions

Novoviah is located in Brisbane, Queensland, AU.

Novoviah generates an estimated annual revenue of $1,112,215. This revenue figure reflects the company's market position and business performance in its industry.

Novoviah has an estimated valuation of $3,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Novoviah was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Novoviah has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Novoviah

Geoff Daly

Director Of Operations

4.8

40,000 users